Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topotecan and Paclitaxel with Chemoradiation in Limited-Stage Small Cell Lung Cancer
NCT00006012Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Feb 2001
- Primary completion
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of topotecan, paclitaxel in small cell lung cancer (SCLC), sponsored by Cancer and Leukemia Group B. Started Feb 2001; status: completed.
02
Drugs
topotecanpaclitaxel
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00006012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006012.